Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cladribine in Mantle Cell Lymphoma
NCT00002879Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 1996
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cladribine in mantle cell lymphoma (MCL), sponsored by Cancer and Leukemia Group B. Started Nov 1996; status: completed.
02
Drugs
cladribine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00002879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002879.